Principal Financial Group’s PDL BioPharma, Inc. PDLI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
Sell
-12,966
Closed -$38K 2393
2020
Q2
$38K Sell
12,966
-102,820
-89% -$325K ﹤0.01% 2293
2020
Q1
$326K Buy
115,786
+11,597
+11% +$37.4K ﹤0.01% 1944
2019
Q4
$338K Buy
104,189
+6,745
+7% +$19.6K ﹤0.01% 2030
2019
Q3
$210K Buy
97,444
+17,841
+22% +$47.7K ﹤0.01% 2135
2019
Q2
$250K Sell
79,603
-8,612
-10% -$27.9K ﹤0.01% 2105
2019
Q1
$328K Sell
88,215
-3,437
-4% -$11.6K ﹤0.01% 2017
2018
Q4
$266K Buy
91,652
+28,434
+45% +$78.1K ﹤0.01% 2057
2018
Q3
$167K Buy
63,218
+22
+0% +$54 ﹤0.01% 2192
2018
Q2
$148K Sell
63,196
-11,375
-15% -$31.8K ﹤0.01% 2194
2018
Q1
$220K Buy
74,571
+4,146
+6% +$11.3K ﹤0.01% 2086
2017
Q4
$193K Sell
70,425
-32,103
-31% -$98.6K ﹤0.01% 2142
2017
Q3
$348K Sell
102,528
-4,272
-4% -$11.9K ﹤0.01% 1999
2017
Q2
$264K Buy
106,800
+50,420
+89% +$116K ﹤0.01% 2078
2017
Q1
$128K Sell
56,380
-3,534
-6% -$7.82K ﹤0.01% 2128
2016
Q4
$127K Buy
59,914
+17,356
+41% +$48.4K ﹤0.01% 2137
2016
Q3
$143K Buy
42,558
+14,256
+50% +$45.3K ﹤0.01% 2074
2016
Q2
$89K Sell
28,302
-1,176
-4% -$3.92K ﹤0.01% 2095
2016
Q1
$98K Buy
29,478
+533
+2% +$1.66K ﹤0.01% 2089
2015
Q4
$102K Buy
28,945
+625
+2% +$2.62K ﹤0.01% 2107
2015
Q3
$142K Buy
28,320
+211
+0.8% +$1.21K ﹤0.01% 2071
2015
Q2
$181K Sell
28,109
-1,172
-4% -$7.85K ﹤0.01% 2055
2015
Q1
$206K Sell
29,281
-131,498
-82% -$952K ﹤0.01% 2020
2014
Q4
$1.24M Sell
160,779
-164,050
-51% -$1.3M ﹤0.01% 1765
2014
Q3
$2.43M Buy
324,829
+68,547
+27% +$636K ﹤0.01% 1617
2014
Q2
$2.48M Sell
256,282
-10,030
-4% -$89.4K ﹤0.01% 1639
2014
Q1
$2.21M Sell
266,312
-415
-0.2% -$3.56K ﹤0.01% 1634
2013
Q4
$2.25M Sell
266,727
-785,488
-75% -$6.62M ﹤0.01% 1643
2013
Q3
$8.39M Buy
1,052,215
+351,789
+50% +$2.83M 0.02% 931
2013
Q2
$5.41M Buy
+700,426
New +$5.46M 0.01% 1146

Other funds holding PDLI